Article
Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048)
Cancer Research
(2015)
Disciplines
Publication Date
August, 2015
DOI
DOI: 10.1158/1538-7445.AM2015-3888
Publisher Statement
Additional authors: Morin R, McNamara S, Couëtoux du Tertre M, McCloskey R, Johnston R, Fornika D, Samson B, Lespérance B, Alcindor T, Ko Y, Dalfen R, St-Hilaire E, Sideris L, Couture F, Prenen H, Tejpar S, Burkes R, Harb M, Constantin A, Camlioglu E, Aguilar A, Gologan A, Tetu B, Greenwood CM, Hoffert C, Qureshi S, Marques M, Witcher M, Gagnon-Kugler T, Kavan P, Batist G.
Citation Information
Zuanel Diaz. "Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048)" Cancer Research Vol. 75 Iss. 15 Supplement (2015) p. 3888 Available at: http://works.bepress.com/zuanel-diaz/19/